3f9n: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
{{Seed}} | {{Seed}} | ||
[[Image:3f9n. | [[Image:3f9n.png|left|200px]] | ||
<!-- | <!-- | ||
Line 12: | Line 12: | ||
===Crystal structure of chk1 kinase in complex with inhibitor 38=== | ===Crystal structure of chk1 kinase in complex with inhibitor 38=== | ||
<!-- | |||
The line below this paragraph, {{ABSTRACT_PUBMED_19155174}}, adds the Publication Abstract to the page | |||
(as it appears on PubMed at http://www.pubmed.gov), where 19155174 is the PubMed ID number. | |||
--> | |||
{{ABSTRACT_PUBMED_19155174}} | |||
==About this Structure== | ==About this Structure== | ||
3F9N is a 1 chain structure of sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=3F9N OCA]. | 3F9N is a 1 chain structure of sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=3F9N OCA]. | ||
==Reference== | |||
<ref group="xtra">PMID:19155174</ref><references group="xtra"/> | |||
[[Category: Homo sapiens]] | [[Category: Homo sapiens]] | ||
[[Category: Non-specific serine/threonine protein kinase]] | [[Category: Non-specific serine/threonine protein kinase]] | ||
Line 36: | Line 45: | ||
[[Category: Ubl conjugation]] | [[Category: Ubl conjugation]] | ||
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Wed | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Wed Apr 29 21:09:53 2009'' |
Revision as of 21:09, 29 April 2009
Crystal structure of chk1 kinase in complex with inhibitor 38Crystal structure of chk1 kinase in complex with inhibitor 38
Template:ABSTRACT PUBMED 19155174
About this StructureAbout this Structure
3F9N is a 1 chain structure of sequence from Homo sapiens. Full crystallographic information is available from OCA.
ReferenceReference
- ↑ Converso A, Hartingh T, Garbaccio RM, Tasber E, Rickert K, Fraley ME, Yan Y, Kreatsoulas C, Stirdivant S, Drakas B, Walsh ES, Hamilton K, Buser CA, Mao X, Abrams MT, Beck SC, Tao W, Lobell R, Sepp-Lorenzino L, Zugay-Murphy J, Sardana V, Munshi SK, Jezequel-Sur SM, Zuck PD, Hartman GD. Development of thioquinazolinones, allosteric Chk1 kinase inhibitors. Bioorg Med Chem Lett. 2009 Feb 15;19(4):1240-4. Epub 2008 Dec 24. PMID:19155174 doi:10.1016/j.bmcl.2008.12.076
Page seeded by OCA on Wed Apr 29 21:09:53 2009